Propeller Gets Another FDA Clearance
Propeller Health announced this week that it was cleared by the FDA to market its platform with medications using GlaxoSmithKline’s Diskus dry powder inhaler. “Today we’re excited to announce back-to-back…
Category Archives: Biotech
Lucigen Lands New Grant
Lucigen announced recently it was awarded an SBIR Phase II grant to continue work on a DNA cloning vector for the growing protein expression market. According to a release, Lucigen…
SHINE Lands $150K Grant
SHINE Medical Technologies has earned a $150,000 SBIR Grant from the National Science Foundation, the medical isotope company announced this week. According to a release, the grant will aid SHINE’s ongoing…
Invenra, OBT to Collaborate
Invenra announced last week that is has teamed up with UK-based biotech company Oxford BioTherapeutics (OBT) to identify and characterize a panel of fully human therapeutic monoclonal antibodies (mAbs) against…
InvivoSciences, Hamamatsu to Collaborate
InvivoSciences and New Jersey-based Hamamatsu today announced a joint collaboration that ultimately may help accelerate preclinical drug discovery in regenerative medicine. According to a release, technology developed by Hamamatsu will be…
Jim Caruso to Head Cellectar
Cellectar Biosciences named Jim Caruso to be its new President and CEO, the company announced today. “(Jim) brings a level of energy and commitment, combined with his significant industry experience that…
UW Startup Creates Antibodies for Animal Infections
University of Wisconsin Animal Sciences Professor Mark Cook has created Ab E Discovery LLC to commercialize research in developing an antibiotic-free method to protect animals raised for food against common infections,…
Exact Sciences Proposes Downtown HQ
Exact Sciences announced today that it may relocate its headquarters to a proposed mixed-use space in Judge Doyle Square. According to a release, Hammes Co. and Majestic Realty are envisioning a 1 million…
Cellectar Begins Multiple Melanoma Trial
Cellectar Biosciences, which develops agents to detect, treat and monitor cancers, announced today it has initiated patient dosing in a proof-of-concept trial of I-131-CLR1404 in those with multiple melanoma. “I-131-CLR1404…
Tasso Earns Additional $2.9M Grant
Medical technology company Tasso announced today it has gained an additional $2.9 million in Phase II SBIR grant funding to advance its HemoLink technology. According to a release, Tasso, along with development partner GenTegra,…
